Publications
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial. KU Leuven
Paving the way for immunotherapy in pancreatic cancer by unravelling its tumour microenvironment and exploring a novel combination immunotherapy consisting of a CD40 agonist and interleukin-15 University of Antwerp
Paving the way for immunotherapy in pancreatic cancer by exploring a novel combination immunotherapy consisting of a CD40 agonist and interleukin-15 University of Antwerp
Targeting lentiviral vectors for cancer immunotherapy. Arce F, Breckpot K, Collins M, Escors D. Curr Cancer Ther Rev. 2011 Nov;7(4):248-260. Vrije Universiteit Brussel
Is the combination of immunotherapy and radiotherapy in non-small cell lung cancer a feasible and effective approach? Ghent University
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells Vrije Universiteit Brussel
Dendritic cells (DCs) can initiate and direct adaptive immune responses. This ability is exploitable in DC vaccination strategies, in which DCs are educated ex vivo to present tumor antigens and are administered into the patient with the aim to induce a tumor-specific immune response. DC vaccination remains a promising approach with the potential to further improve cancer immunotherapy with little or no evidence of treatment-limiting ...
A personalized view on cancer immunotherapy. Vrije Universiteit Brussel
RNA in cancer immunotherapy Vrije Universiteit Brussel
Recent advances in the manufacturing, modification, purification and cellular delivery of ribonucleic acid (RNA) have enabled the development of RNA-based therapeutics for a broad array of applications. The approval of two SARS-CoV-2-targeting mRNA-based vaccines has highlighted the advances of this technology. Offering rapid and straightforward manufacturing, clinical safety and versatility, this paves the way for RNA therapeutics to expand ...